bioAffinity Technologies prices USD 4 million private placement at USD 0.47 per share unit
BIAF•Closing timing and placement agent
Closing is expected around Aug. 14, 2026, subject to customary conditions.
WallachBeth Capital is the sole placement agent.
Private placement pricing and structure
bioAffinity Technologies priced a USD 4 million private placement, selling 8,462,027 common shares or pre-funded warrants.
Investors also receive two warrants for up to 16,924,054 shares; the warrant exercise price is USD 0.47, exercisable after stockholder approval.
The combined effective offering price was set at USD 0.47 per share with warrants; the pre-funded warrant structure is also priced at USD 0.47.
